Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

PFE) has had a rough month with its share price down 2.9%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Stock ...

Pfizer (PFE) has been one of the most searched-for ... between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Pfizer is expected to post ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

1 Day PFE 1.00% DJIA -0.38% S&P 500 -0.01% Health Care/Life Sciences -0.46% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...